Trials / Completed
CompletedNCT02875652
Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)
Study of Circulating Tumoral DNA Evolution in Plasma in Choroidal Melanoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 800 (actual)
- Sponsor
- Institut Curie · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Quantification and follow-up during 3 years of circulating tumoral DNA in patients with choroidal melanoma
Detailed description
This study is a prospective, open-labelled, monocentric trial. The aim is to observe, in patient with choroidal melanoma (any stage of the disease), the prevalence of the circulating tumor DNA at the diagnostic and its evolution during 3 years. The patient will have a blood sample at the following times : * T0: before treatment of the primary tumor. * T1: 1 months after the end of the local treatment. * T2: at 7 months. * Tn: every 6 months up to 3 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood sampling | 3 vials of 7,5 ml of peripherical blood will be collected at each blood sample. |
Timeline
- Start date
- 2013-03-21
- Primary completion
- 2019-04-02
- Completion
- 2019-04-02
- First posted
- 2016-08-23
- Last updated
- 2024-01-31
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02875652. Inclusion in this directory is not an endorsement.